质子束治疗与光子放疗在局部晚期食管鳞癌中的剂量学比较
本研究对37例III期胸段食管鳞癌患者(其中27例数据可分析)的质子束治疗(PBT)剂量分布与模拟三维适形放疗(3DCRT)及调强放疗(IMRT)进行比较,重点评估正常肺和心脏受量。结果显示PBT较3DCRT和IMRT均显著降低肺和心脏剂量,但2级心包积液的发生与心脏剂量无显著相关性。
要点
- PBT较3DCRT显著降低肺剂量(除V10 GyE和V15 GyE外)及心脏剂量。
- PBT较IMRT显著降低所有肺和心脏剂量学参数。
- 2级心包积液发生率15%,与心脏剂量参数无显著相关性。
核心结论
- 对于局部晚期III期食管鳞癌,PBT较3DCRT或IMRT能显著降低肺和心脏的剂量。
研究设计与样本
- 本研究为剂量学比较研究,纳入2012年10月至2015年12月在本机构接受PBT(伴或不伴同步化疗)的37例连续III期胸段食管鳞癌患者,最终分析27例患者数据,将PBT剂量分布与模拟3DCRT和IMRT计划进行比较。
主要发现
- 27例可分析患者中,4例(15%)出现2级心包积液作为晚期毒性,无患者出现3级或更严重的急慢性肺或心脏毒性。
- PBT较模拟3DCRT计划,除肺V10 GyE和V15 GyE外,所有肺剂量学参数均显著更低,心脏剂量学参数也均显著更低。
- PBT较模拟IMRT计划,所有肺和心脏剂量学参数均显著更低。
- 2级心包积液的发生与心脏剂量之间无显著相关性。
临床怎么用
- 对于局部晚期III期胸段食管鳞癌,PBT在降低肺和心脏受量方面优于3DCRT和IMRT,可能有助于减少心肺毒性。
局限性
- 本研究为单中心剂量学比较研究,样本量有限(27例可分析),且毒性分析为观察性,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to perform a dosimetric comparison between proton beam therapy (PBT) and photon radiation therapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who were treated with PBT in our institution. In addition, we evaluated the correlation between toxicities and dosimetric parameters, especially the doses to normal lung or heart tissue, to clarify the clinical advantage of PBT over photon radiation therapy. METHODS: A total of 37 consecutive patients with Stage III thoracic ESCC who had received PBT with or without concurrent chemotherapy between October 2012 and December 2015 were evaluated in this study. The dose distributions of PBT were compared with those of dummy 3-dimensional conformal radiation therapy (3DCRT) and Intensity Modulated Radiation Therapy (IMRT), focusing especially on the doses to organs at risk, such as normal lung and heart tissue. RESULTS: Of the 37 patients, the data from 27 patients were analyzed. Among these 27 patients, four patients (15%) developed grade 2 pericardial effusion as a late toxicity. None of the patients developed grade 3 or worse acute or late pulmonary and cardiac toxicities. When the dosimetric parameters between PBT and planned 3DCRT were compared, all the PBT domestic variables for the lung dose except for lung V10 GyE and V15 GyE were significantly lower than those for the dummy 3DCRT plans, and the PBT domestic variables for the heart dose were also significantly lower than those for the dummy 3DCRT plans. When the PBT and IMRT plans were compared, all the PBT domestic variables for the doses to the lung and heart were significantly lower than those for the dummy IMRT plans. Regarding the correlation between the grades of toxicities and the dosimetric parameters, no significant correlation was seen between the occurrence of grade 2 pericardial effusion and the dose to the heart. CONCLUSIONS: When the dosimetric parameters of the dose distributions for the treatment of patients with locally advanced stage III ESCC were compared between PBT and 3DCRT or IMRT, PBT enabled a significant reduction in the dose to the lung and heart, compared with 3DCRT or IMRT.
引用
- Hirano Y, Onozawa M, Hojo H, et al. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. Radiat Oncol. 2018. PMID: 29426342. doi:10.1186/s13014-018-0966-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。